Latest market price
36.35
-0.53-1.45%
ASTHQT58Astrana Health, Inc.·NASDAQ
36.35-1.45%
TA
Loading chart...
Screen all →
Snapshot
Index—P/E44.98EPS (ttm)0.82Insider Own42.74%Shs Outstand49.60MPerf Week-0.94%
Market Cap1.83BForward P/E18.62EPS next Y1.98Insider Trans0.00%Shs Float37.95MPerf Month2.79%
Enterprise Value2.40BPEG1.62EPS next Q0.46Short Float7.93%Perf Quarter3.39%
Income40.00MP/S0.48EPS this Y186.32%Short Ratio6.83Perf Half Y5.43%
Sales3.85BP/B3.05EPS next Y40.49%ROA1.78%Short Interest3.01MPerf YTD48.65%
Book/sh12.08P/C4.56EPS next 5Y27.79%ROE5.09%52W High51.60 -29.56%Perf Year15.94%
Cash/sh8.08P/FCF11.58EPS past 3/5Y-22.55% -14.55%ROIC4.10%52W Low18.08 101.03%Perf 3Y21.76%
Dividend Est.—EV/EBITDA12.63Sales past 3/5Y40.63% 53.78%Gross Margin9.22%Volatility3.35% 3.91%Perf 5Y-49.02%
Dividend TTM—EV/Sales0.62EPS Y/Y TTM57.21%Oper. Margin2.61%ATR (14)1.49Perf 10Y883.47%
Dividend Ex-Date—Quick Ratio1.23Sales Y/Y TTM58.95%Profit Margin1.05%RSI (14)48.99Recom2.00
Dividend Gr. 3/5Y—Current Ratio1.23EPS Q/Q110.53%SMA20-1.07%Beta1.21Target Price52.00
Payout4.82%Debt/Eq1.62Sales Q/Q48.55%SMA50-0.42%Rel Volume0.72Prev Close36.88
Employees3,000LT Debt/Eq1.53EarningsNov 05SMA2008.84%Avg Volume383.09KPrice36.35
IPO DateMar 11, 2009Option/ShortYes / YesEPS/Sales Surpr.19.13% -0.99%Net Debt/EBITDA3.00Volume275,814Change-1.45%
Analyst Ratings
DateActionAnalystRatingTarget
Sep-15-26InitiatedOppenheimerOutperform$53
Aug-07-26ReiteratedBarclaysOverweight$50 → $53
Jul-14-26ReiteratedBTIGBuy$40 → $65
May-26-26UpgradeBarclaysEqual Weight → Overweight$37 → $50
May-14-26ReiteratedTruist SecuritiesBuy$47
May-11-26ReiteratedBarclaysEqual Weight$26 → $37
May-08-26ReiteratedRobert W. Baird$40 → $45
May-08-26ReiteratedNeedhamBuy$28 → $41
Apr-15-26ReiteratedRobert W. Baird$37 → $40
Feb-02-26ReiteratedBTIGBuy$70 → $40
Latest News· Times ET
Oct-31-26
Oct-28-26
Oct-22-26
Oct-20-26
Oct-19-26
Oct-13-26
Oct-12-26
Oct-09-26
Oct-08-26
Oct-07-26
Oct-06-26
Oct-05-26
Sep-30-26
Company

Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue3,8453,1822,0351,387—————
Cost of Goods Sold Incl. D&A3,4892,8861,7631,172—————
Gross Profit355296271215—————
Selling, General and Administrative Excl. Other239217154113—————
Research and Development
0000—————
Other Operating Expense1502817—————
Operating Income100798985—————
Interest Expense68503316—————
Unusual Expense
—————————
Non-Operating Income (Expense)27112521—————
Net Income Before Taxes61408190—————
Income Taxes22163132—————
Consolidated Net Income40224361—————
Net Income From Continuing Operations39245058—————
Net Income40224361—————
EPS (Recurring)0.830.460.911.30—————
EPS (Basic, Before Extraordinaries)0.830.460.911.30—————
EPS (Diluted)0.820.460.901.29—————
EBITDA190135142124—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio44.3253.9335.0329.69—————
Price To Sales Ratio0.460.380.741.30—————
Gross Margin9.239.3013.3215.50—————
Operating Margin2.602.484.376.13—————
Net Margin1.040.692.114.40—————
Shares Outstanding49494847—————
Market Capitalization1,7811,2161,5131,800—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$54.56$44.27$33.98$23.70$13.41● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Schmidt DavidDirectorAug 14 '26Option Exercise5.0020,000100,00056,019Aug 18
Sim BrandonCEO and PresidentFeb 02 '26Option Exercise23.2421,334495,8021,045,329Feb 03
Schmidt DavidDirectorJan 13 '26Option Exercise5.7920,000115,80035,763Jan 15
Lam Thomas S.DirectorDec 08 '25Option Exercise17.7829,502524,546459,122Dec 10
Sim Kenneth T.Executive ChairmanNov 10 '25Option Exercise17.7829,502524,546639,407Nov 13
Mazdyasni MatthewDirectorNov 10 '25Option Exercise18.2020,000364,00034,763Nov 12
Kitayama Mitchell WDirectorNov 07 '25Option Exercise18.2012,000218,40027,846Nov 12
Marsh LindaDirectorNov 03 '25Option Exercise18.2020,000364,000103,641Nov 05
Kitayama Mitchell WDirectorSep 15 '25Option Exercise18.208,000145,60029,060Sep 15
Schmidt DavidDirectorSep 02 '25Option Exercise18.2020,000364,00035,763Sep 03
Chiang JohnDirectorAug 13 '25Option Exercise18.2020,000364,00043,132Aug 14
Kitayama Mitchell WDirectorNov 22 '24Option Exercise18.413,40962,76021,201Nov 26
Chiang JohnDirectorNov 19 '24Option Exercise18.411,51527,89117,364Nov 20
Sim Kenneth T.Executive ChairmanNov 18 '24Option Exercise18.6528,046523,058609,905Nov 20
Marsh LindaDirectorSep 10 '24Option Exercise15.3511,000168,85080,714Sep 12
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.